Teishima, J., Hara, T., Tobe, T., Hirata, J., Ueki, H., Wakita, N., Shiraishi, Y., Okamura, Y., Bando, Y., Terakawa, T., Furukawa, J., Harada, K.- ichi, Nakano, Y., & Fujisawa, M. (2024). Therapeutic outcome of combination therapy using immune-checkpoint inhibitors and tyrosine kinase inhibitors for metastatic non-clear-cell renal cell carcinoma . Canadian Urological Association Journal, 18(5), E162–6. https://doi.org/10.5489/cuaj.8548